Ishita Drugs & Industries Ltd

₹ 74.0 -3.32%

24 Aug - close price

About

Incorporated in 1992, Ishita Drugs & Industries
Ltd is engaged in the manufacturing of various APIs and drug intermediates^[1]

Key Points

Business Overview:^[1]^[2]
IDIL is a flagship company of Ishita
Group. It is in the business of manufacturing
and sale of Bulk Drugs, Fine Chemicals, and Intermediates. The company supplies
its products to pharmaceutical companies
in India and abroad

Website BSE

Market Cap ₹ 22.1 Cr.
Current Price ₹ 74.0
High / Low ₹ 90.8 / 66.0
Stock P/E 31.2
Book Value ₹ 38.7
Dividend Yield 0.00 %
ROCE 8.66 %
ROE 6.98 %
Face Value ₹ 10.0

Add ratio to table

Edit ratios

Pros

Company has reduced debt.
Company is almost debt free.

Cons

Though the company is reporting repeated profits, it is not paying out dividend
The company has delivered a poor sales growth of 1.00% over past five years.
Company has a low return on equity of 7.72% over last 3 years.
Earnings include an other income of Rs.0.43 Cr.
Working capital days have increased from 65.9 days to 146 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns

Loading peers table ...

Detailed Comparison with:

Quarterly Results

Figures in Rs. Crores

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	3.09	4.40	3.21	4.50	3.03	3.27	4.13	4.56	5.40	3.07	3.14	3.06	3.15
	2.91	4.18	2.99	4.20	2.86	3.03	3.83	4.27	5.06	2.89	3.00	2.96	2.84
Operating Profit	0.18	0.22	0.22	0.30	0.17	0.24	0.30	0.29	0.34	0.18	0.14	0.10	0.31
OPM %	5.83%	5.00%	6.85%	6.67%	5.61%	7.34%	7.26%	6.36%	6.30%	5.86%	4.46%	3.27%	9.84%
	0.07	0.10	0.01	0.10	0.06	0.05	0.07	0.16	0.09	0.07	0.10	0.22	0.04
Interest	0.03	0.01	0.04	0.02	0.01	0.00	0.02	0.04	0.02	0.00	0.02	0.02	0.00
Depreciation	0.03	0.03	0.03	0.01	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.02	0.05
Profit before tax	0.19	0.28	0.16	0.37	0.19	0.26	0.32	0.38	0.38	0.22	0.19	0.28	0.30
Tax %	26.32%	25.00%	25.00%	24.32%	26.32%	23.08%	25.00%	23.68%	23.68%	36.36%	21.05%	35.71%	23.33%
	0.14	0.21	0.12	0.28	0.15	0.19	0.24	0.29	0.30	0.14	0.16	0.18	0.23
EPS in Rs	0.47	0.70	0.40	0.94	0.50	0.64	0.80	0.97	1.00	0.47	0.54	0.60	0.77
Raw PDF

Profit & Loss

Figures in Rs. Crores

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
	7.54	7.10	6.44	6.90	9.09	14.83	13.95	14.09	12.07	15.19	15.00	14.66	12.42
	7.23	6.82	6.08	6.45	8.57	14.07	13.03	13.01	11.31	14.28	14.01	13.89	11.69
Operating Profit	0.31	0.28	0.36	0.45	0.52	0.76	0.92	1.08	0.76	0.91	0.99	0.77	0.73
OPM %	4.11%	3.94%	5.59%	6.52%	5.72%	5.12%	6.59%	7.67%	6.30%	5.99%	6.60%	5.25%	5.88%
	0.17	0.13	0.08	0.12	0.16	0.16	0.31	0.11	0.20	0.28	0.34	0.47	0.43
Interest	0.04	0.06	0.04	0.11	0.06	0.03	0.03	0.02	0.05	0.09	0.07	0.06	0.04
Depreciation	0.15	0.15	0.14	0.14	0.16	0.18	0.15	0.13	0.13	0.11	0.11	0.10	0.13
Profit before tax	0.29	0.20	0.26	0.32	0.46	0.71	1.05	1.04	0.78	0.99	1.15	1.08	0.99
Tax %	24.14%	30.00%	30.77%	25.00%	26.09%	23.94%	20.95%	23.08%	25.64%	24.24%	25.22%	27.78%
	0.22	0.14	0.18	0.25	0.35	0.55	0.83	0.80	0.58	0.75	0.87	0.78	0.71
EPS in Rs	0.74	0.47	0.60	0.84	1.17	1.84	2.78	2.68	1.94	2.51	2.91	2.61	2.38
Dividend Payout %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Compounded Sales Growth
10 Years:	8%
5 Years:	1%
3 Years:	7%
TTM:	-28%

Compounded Profit Growth
10 Years:	19%
5 Years:	-1%
3 Years:	10%
TTM:	-30%

Stock Price CAGR
10 Years:	16%
5 Years:	12%
3 Years:	2%
1 Year:	-3%

Return on Equity
10 Years:	7%
5 Years:	8%
3 Years:	8%
Last Year:	7%

Balance Sheet

Figures in Rs. Crores

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	2.99	2.99	2.99	2.99	2.99	2.99	2.99	2.99	2.99	2.99	2.99	2.99
Reserves	2.50	2.64	2.82	3.07	3.42	3.97	4.80	5.61	6.18	6.93	7.80	8.58
	0.09	1.13	0.01	0.13	0.20	0.29	0.04	0.00	0.96	0.00	3.90	0.08
	1.37	1.43	1.37	0.97	1.73	2.30	1.43	2.66	1.27	0.89	1.60	0.95
Total Liabilities	6.95	8.19	7.19	7.16	8.34	9.55	9.26	11.26	11.40	10.81	16.29	12.60
	1.26	1.11	1.02	1.19	1.30	1.14	1.00	0.88	0.89	0.80	0.88	0.88
CWIP	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.75
Investments	1.82	2.15	2.70	3.15	4.04	5.29	3.11	4.06	3.39	3.34	3.87	4.45
	3.87	4.93	3.47	2.82	3.00	3.12	5.15	6.32	7.12	6.67	11.54	5.52
Total Assets	6.95	8.19	7.19	7.16	8.34	9.55	9.26	11.26	11.40	10.81	16.29	12.60

Cash Flows

Figures in Rs. Crores

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	0.11	0.26	0.52	0.72	0.79	1.05	-0.67	3.08	-2.90	2.12	-3.64	3.92
	-0.34	-0.28	-0.55	-0.69	-1.06	-1.15	2.45	-0.93	0.59	0.13	-0.67	-2.24
	-0.07	1.07	-1.05	0.05	0.09	0.09	-0.24	0.00	1.05	-0.87	4.33	-3.81
Net Cash Flow	-0.29	1.05	-1.08	0.08	-0.19	-0.01	1.54	2.14	-1.25	1.38	0.02	-2.13
Free Cash Flow	0.06	0.25	0.48	0.41	0.52	1.04	-0.67	3.06	-3.03	2.09	-3.82	2.07
CFO/OP	35%	93%	144%	160%	152%	138%	-73%	285%	-382%	233%	-368%	509%

Ratios

Figures in Rs. Crores

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	60.51	96.65	96.35	43.38	47.38	32.24	39.77	13.99	54.43	16.82	46.23	25.15
Inventory Days	91.60	55.65	51.49	55.56	42.20	18.49	23.06	34.81	68.22	34.27	152.28	32.57
Days Payable	78.31	91.07	108.49	43.21	78.70	60.25	34.76	73.22	36.67	14.87	32.44	19.83
Cash Conversion Cycle	73.80	61.23	39.35	55.72	10.88	-9.52	28.07	-24.41	85.99	36.22	166.08	37.89
Working Capital Days	64.38	10.28	56.68	32.27	8.03	-10.83	29.83	-27.46	42.94	21.87	30.17	145.65
ROCE %	5.98%	4.21%	4.77%	7.16%	8.12%	10.68%	14.32%	12.90%	8.86%	10.77%	9.91%	8.66%

Insights

In beta

Mar 2016

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Electricity Purchased
KWH

xxx,xxx	xxx,xxx	xxx,xxx	xxx,xxx	xx,xxx	xx,xxx	xx,xxx	xx,xxx	xx,xxx	xx,xxx
x,xxx,xxx	x,xxx,xxx	x,xxx,xxx	x,xxx,xxx	x,xxx,xxx	xx,xxx,xxx	xx,xxx,xxx	xx,xxx,xxx	xx,xxx,xxx	x,xxx,xxx
xx.xx	xx.xx	xx.xx	xx.xx	xx.xx	xx.xx	xx.xx	xx.xx	xx.xx	xx.xx
xx	xx	xx	xx	xx	xx	xx	xx	xx	xx
xxx,xxx	xxx,xxx	xxx,xxx	xxx,xxx	xxx,xxx	xxx,xxx	xxx,xxx	xxx,xxx	xxx,xxx	xxx,xxx

Please log in to see hidden values.

Foreign Exchange Earnings (Exports)
INR

Imported Raw Material Share
% of total raw material consumed

Permanent Employees on Rolls
persons

R&D Expenditure
INR

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

2 Recently

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	49.38%	49.38%	49.42%	49.80%	49.80%	49.85%	49.91%	49.92%	49.96%	50.04%	50.04%	50.04%
	50.62%	50.62%	50.58%	50.20%	50.19%	50.14%	50.08%	50.09%	50.04%	49.95%	49.97%	49.96%
No. of Shareholders	5,134	5,283	5,351	5,272	5,555	5,412	5,398	5,341	5,320	5,263	5,194	5,146

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	Jun 2026
	47.05%	47.05%	47.70%	47.78%	47.87%	49.31%	49.38%	49.42%	49.91%	50.04%	50.04%
	52.95%	52.95%	52.30%	52.22%	52.13%	50.69%	50.60%	50.58%	50.08%	49.97%	49.96%
No. of Shareholders	4,722	4,569	4,517	4,500	4,425	4,847	4,899	5,351	5,398	5,194	5,146

Documents

Announcements

All

Ishita Drugs & Industries Ltd

Ishita Drugs & Industries Ltd

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flows

Ratios

Insights

Shareholding Pattern

Documents

Announcements

Annual reports